Greenwood Capital Associates’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,580
| Closed | -$368K | – | 246 |
|
|
2024
Q3 | $368K | Sell |
5,580
-50,235
| -90% | -$3.32M | 0.05% | 203 |
|
|
2024
Q2 | $5.16M | Sell |
55,815
-29,495
| -35% | -$2.72M | 0.68% | 52 |
|
|
2024
Q1 | $8.15M | Sell |
85,310
-6,543
| -7% | -$625K | 1.08% | 25 |
|
|
2023
Q4 | $7M | Buy |
91,853
+1,563
| +2% | +$119K | 0.91% | 39 |
|
|
2023
Q3 | $6.26M | Sell |
90,290
-21,693
| -19% | -$1.5M | 0.91% | 33 |
|
|
2023
Q2 | $10.6M | Buy |
111,983
+15,492
| +16% | +$1.46M | 1.48% | 11 |
|
|
2023
Q1 | $7.98M | Buy |
+96,491
| New | +$7.98M | 1.15% | 27 |
|
|
2018
Q4 | – | Sell |
-16,155
| Closed | -$938K | – | 173 |
|
|
2018
Q3 | $938K | Buy |
16,155
+225
| +1% | +$13.1K | 0.2% | 79 |
|
|
2018
Q2 | $773K | Buy |
15,930
+9,081
| +133% | +$441K | 0.18% | 85 |
|
|
2018
Q1 | $319K | Buy |
6,849
+951
| +16% | +$44.3K | 0.08% | 135 |
|
|
2017
Q4 | $222K | Buy |
5,898
+39
| +0.7% | +$1.47K | 0.05% | 187 |
|
|
2017
Q3 | $213K | Sell |
5,859
-93
| -2% | -$3.38K | 0.05% | 184 |
|
|
2017
Q2 | $235K | Buy |
+5,952
| New | +$235K | 0.06% | 161 |
|